🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to determine the effect of two dose strength...
Status
Completed
Location
Acorda Site #117
Start Date
2014-12
Trial ID
NCT02271217
Treatments Being Tested
The purpose of this study is to investigate the safety and efficacy of a lo...
Status
Completed
Location
North Central Neurology Associates, PC
Start Date
2011-03
Trial ID
NCT01328379
Treatments Being Tested
The purpose of this study is to determine changes on overall gait as well a...
Status
Completed
Location
OMRF Multiple Sclerosis Center of Excellence
Start Date
2012-01
Trial ID
NCT01535664
Treatments Being Tested
The only approved treatment for impaired ambulation in MS is Dalfampridine ...
Status
Unknown
Location
Ain Shams Univeristy
Start Date
2021-06-01
Trial ID
NCT05730738
Treatments Being Tested
A double-blind, placebo-controlled, crossover study in subjects with cerebr...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2011-12
Trial ID
NCT01468350
Treatments Being Tested
The investigators have found recent promising data supporting the use of a ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-11
Trial ID
NCT06294821
Treatments Being Tested
A randomized placebo controlled double-blind cross-over trial of Dalfamprid...
Status
Completed
Location
MS Center at Evergreen
Start Date
2010-11
Trial ID
NCT01356940
Treatments Being Tested
This is a multi-center, safety and tolerability study in subjects with chro...
Status
Completed
Location
Acorda Site #011
Start Date
2012-05
Trial ID
NCT01605825
Treatments Being Tested